Abstract:Esophageal squamous cell carcinoma (ESCC) is one of the most predominant subtypes of esophageal cancer. The characteristics of the gut microbiome and its metabolites from patients with ESCC have not been adequately studied and discussed. In this study, 40 fecal samples (20 from ESCC patients and 20 from healthy controls) were analyzed by 16S rRNA gene sequencing and untargeted metabolomics. The data sets were analyzed individually and synthesized using various bioinformatics methods. Alpha and beta diversity indicated significant differences in microbial diversity and abundance between ESCC and healthy control feces. At the genus level, the abundance of Phascolarctobacterium, Sutterella, and Streptococcus was significantly increased in ESCC. At the genus level, linear discriminant analysis effect size identified two biomarkers: Bacteroides_stercoris and Prevotella_copri. Untargeted metabolomics analysis revealed 307 differential metabolites between ESCC and healthy control feces, with indoles and derivatives, tropane alkaloids, lipids, and lipid-like molecules in higher relative abundance in ESCC feces than in healthy control feces. Kyoto Encyclopedia of Genes and Genomes enrichment analysis revealed that unsaturated fatty acids (FAs), ascorbate and aldarate metabolism, and hypoxia-inducible factor 1 signaling pathway were significantly associated with differential metabolite. Phenylethanolamine and despropionyl p-fluoro fentanyl could be used as reliable biomarkers to differentiate ESCC from healthy control. The correlation analysis showed that Prevotella may be involved in the synthesis of fatty acyl, carboxylic acids and derivatives, benzenes and substituted derivatives, organic oxygenates, and indoles and derivatives as metabolites. Fusicatenibacter and Lachnospira may be involved in the degradation of indoles and derivatives. Alistipes, Agathobacter, and Parabacteroides may be involved in the synthesis of indoles and derivatives with strong contributions. There is an intricate relationship between the gut microbiome and the levels of several metabolites (e.g., fatty acyls, carboxylic acids and derivatives, indoles, and derivatives). Microbial-associated metabolites can be used as diagnostic biomarkers in therapeutic exploration. Further analysis revealed that Prevotella, Alistipes, Agathobacter, and Parabacteroides might promote ESCC by regulating the synthesis of indoles and their derivatives. The results of this study provide favorable evidence for the early diagnosis of ESCC and subsequent individualized treatment and targeted interventions.IMPORTANCEWe describe for the first time the differences in fecal microbiome composition and metabolites between patients with esophageal squamous cell carcinoma (ESCC) and healthy controls by 16S rRNA gene sequencing and untargeted metabolomics. The results of this study provide a favorable basis for the early diagnosis of ESCC and subsequent targeted interventional therapy.

Integrative Proteomic Characterization of Trace FFPE Samples in Early-Stage Gastrointestinal Cancer

LC-MS proteomic profiling of trace FFPE samples in gastrointestinal cancer

Integrative proteogenomic characterization of early esophageal cancer

Additional File 3 of Integrative Proteomic Characterization of Trace FFPE Samples in Early-Stage Gastrointestinal Cancer

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues.

Data-independent acquisition for proteomic applications in early-stage endometrial cancer progression

Functional Proteomic Profiling Analysis in Four Major Types of Gastrointestinal Cancers.

Proteomic Analysis of Human Esophageal Cancer Using Tandem Mass Tag Quantifications

Discovery and Validation of Combined Biomarkers for the Diagnosis of Esophageal Intraepithelial Neoplasia and Esophageal Squamous Cell Carcinoma

Title Comparative proteomic analysis of esophageal squamous cellcarcinoma

N-linked glycoproteomic profiling in esophageal squamous cell carcinoma

Integrative proteomic characterization of adenocarcinoma of esophagogastric junction

iTRAQ-Based Quantitative Proteomic Analyses of High Grade Esophageal Squamous Intraepithelial Neoplasia.

Integrating Proteomics and Transcriptomics for the Identification of Potential Targets in Early Colorectal Cancer

Lipid Profiling for Early Diagnosis and Progression of Colorectal Cancer Using Direct-Infusion Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.

Comprehensive serum proteomics profiles and potential protein biomarkers for the early detection of advanced adenoma and colorectal cancer

Novel proteomic strategy reveal combined α1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening

Proteomic analysis of minute amount of colonic biopsies by enteroscopy sampling

Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma

Comparative Proteomic Analysis of Esophageal Squamous Cell Carcinoma